274 results on '"Sjöqvist, Folke"'
Search Results
2. Inherited Amplification of an Active Gene in the Cytochrome P450 CYP2D Locus as a Cause of Ultrarapid Metabolism of Debrisoquine
3. Clinical Pharmacology in European health care—outcome of a questionnaire study in 31 countries
4. Development of Clinical Pharmacology as a Medical Speciality in Europe – The Roles of WHO, IUPHAR and EACPT
5. The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology
6. The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro
7. The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm
8. Merck fellowships contribute to the continued growth of clinical pharmacology in Sweden
9. Clinical Pharmacokinetics: The First 30 Years
10. Treatment of depression with E-10-hydroxynortriptyline — a pilot study on biochemical effects and pharmacokinetics
11. Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype
12. Mutations of the CYP2C9 gene and the response to warfarin
13. Non-responders in clinical pharmacology – a commentary to a book review by D.N. Bateman
14. Drug Safety in Relation to Efficacy: The View of a Clinical Pharmacologist
15. Pharmacokinetics of nortriptyline and its 10-hydroxy metabolite in Chinese subjects of different CYP2D6 genotypes
16. The CYP2D6 genotype predicts the oral clearance of the neuroleptic agents perphenazine and zuclopenthixol
17. EACPT 2001 in Odense was a success: now we are heading to Istanbul
18. Relationship Between Plasma Level And Therapeutic Effect Of Nortriptyline
19. European Journal of Clinical Pharmacology becomes the official organ of European Association for Clinical Pharmacology and Therapeutics
20. Stereospecific 10-hydroxylation of nortriptyline — genetic aspects and importance for biochemical and clinical effects
21. EFFECTS OF CHLORIMIPRAMINE ON AMINE METABOLITES IN CEREBROSPINAL FLUID OF DEPRESSED PATIENTS - RELATIONSHIP TO INHIBITION OF SEROTONIN UPTAKE
22. Treatment of Depression — Pharmacokinetic and Pharmacogenetic Considerations
23. Active metabolites of antidepressants: novel aspects of hydroxylation and demethylation in man
24. A Pharmacokinetic Approach to the Treatment of Depression
25. Pharmakokinetische und genetische Gesichtspunkte über den Metabolismus von Isoniazid, p-Aminosalicylsäure und Rifampicin
26. Plasma concentrations of diphenylhydantoin in young infants
27. Depot haloperidol treatment in outpatients with schizophrenia on monotherapy : impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcome
28. Clinical Pharmacology in Research, Teaching and Health Care
29. Acetylator Phenotype in Patients with Hydralazine-induced Lupoid Syndrome
30. Editorial
31. Introduction
32. Pharmacokinetics and Biological Effects of Nortriptyline in Man
33. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and inhuman intestinal epithelial Caco-2 cell monolayers
34. Use of doping agents, particularly anabolic steroids, in sports and society
35. Depot Haloperidol Treatment in Outpatients With Schizophrenia on Monotherapy: Impact of CYP2D6 Polymorphism on Pharmacokinetics and Treatment Outcome
36. The Use of TDM Data to Assess the Validity of Defined Daily Doses of Antiepileptics: A Comparison Between a Czech and Swedish University Hospital
37. Therapeutic Monitoring of Antiepileptic Drugs: A Comparison Between a Czech and a Swedish University Hospital
38. Pharmacogenetic Methods as a Complement to Therapeutic Monitoring of Antidepressants and Neuroleptics
39. Validation of Methods for CYP2C9 Genotyping: Frequencies of Mutant Alleles in a Swedish Population
40. No Association Between Familial Alzheimer Disease and Cytochrome P450 Polymorphisms
41. Ulcer surgery in Estonia, a consequence of drug delay?
42. Cytochrome P450 hereditary polymorphism in old people.
43. Quick Onset of Severe Abdominal Pain After Codeine in an Ultrarapid Metabolizer of Debrisoquine
44. The Use of Antidepressants and Therapeutic Drug Monitoring by General Practitioners and Psychiatrists: Findings from a Questionnaire Survey in Two Swedish Areas
45. The Use of Therapeutic Drug Monitoring Data to Document Kinetic Drug Interactions
46. Polymorphism of Debrisoquine and Mephenytoin Hydroxylation among Estonians
47. Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin
48. Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population
49. Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype
50. Diazepam metabolism in native Chinese poor and extensive hydroxylators of S-mephenytoin: Interethnic differences in comparison with white subjects
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.